Feature image

What's New

Prescriber Update 46(3) September 2025

We've published the latest issue of Prescriber Update.

This issue contains important safety information about fluoroquinolone antibiotics, medicines to treat ADHD in adults, systemic retinoids, and more.

Prescriber Update 46(3) September 2025

News and Events

Date Type Title
7/1/2026NoticesNotice of Medsafe Office Closure Christmas/New Year 2025/2026
4/9/2025CommitteesClassification Database was updated on 3 September 2025
4/9/2025CommitteesRecent New Zealand Gazette Notices Relating to Classification
4/9/2025PublicationsPrescriber Update Vol. 46. No. 3 - September 2025
19/8/2025NoticesMedsafe performance statistics 2024/2025
13/8/2025ConsultationClozapine: Proposed changes to blood monitoring and prescribing requirements - consultation questions for consumers and families - closes 8 October 2025
13/8/2025ConsultationClozapine: Proposed changes to blood monitoring and prescribing requirements - consultation questions for healthcare professionals - closes 8 October 2025
31/7/2025CommitteesMedicines Classification Committee - Dates and Deadlines
31/7/2025Monitoring CommunicationUpdate - Anti-CD20 monoclonal antibodies (rituximab, ocrelizumab, obinutuzumab, ofatumumab) and the possible risk of pyoderma gangrenosum
24/7/2025NoticesGuidelines and Application Form for Approval to Prescribe Psychedelics
23/7/2025ConsultationTopical corticosteroids: Proposal for the package labelling to state their potency - Consultation now closes on 13 August 2025
22/7/2025Alert CommunicationWarning: advertisements claiming Medsafe approval or bearing the Medsafe logo are scams